Pyridin
2,99 €
Chemisches Reagenz Pirydyna (CAS 110-86-1). Vollständige enzyklopädische Karte — Klassifizierung, Eigenschaften und Sicherheitsdaten — unten.
🔒 Demomodus — dieser Artikel steht nicht zum Verkauf.
Legale Substanz. dhscientific.com ist eine Demonstration der MOL-GOD-Plattform — wir verkaufen nichts und es werden keine Bestellungen ausgeführt. Verbotene Substanzen werden hier automatisch anhand des regulatorischen Kanons blockiert (vgl. z. B. Heptachlor).
Prüfung Ihres Sicherheitsdatenblatts — kostenlos → · Kontakt
Chemische Übersicht: PyridineMolGod_OVERVIEW_1
| Summenformel | C5H5N |
| Molekulargewicht | 79.10 g/mol |
| Schmelzpunkt | -41.6 °C |
| Siedepunkt | 115.2 °C |
| Dichte | 0.9819 g/cm³ |
| LogP (Lipophilie) | 0.65 |
| pKa | 5.25 |
| IUPAC-Name | pyridine |
| SMILES | C1=CC=NC=C1 |
| InChIKey | JUJWROOIHBZHMG-UHFFFAOYSA-N |
Synonyme: PYRIDINE · 110-86-1 · Azabenzene · Azine · Pyridin
Datenquellen: PubChem (NLM/NIH), Reid, Prausnitz, Poling 4th ed. (1987)
Zuletzt aktualisiert: 2026-11-10
WISSENSCHAFTLICHE FORSCHUNG
📚 Wissenschaftliche Referenzen (Chicago Author-Date) 12 refs · 4 baz
MOLEKUŁA Bibliografie pro CAS (live aus 13+ Datenbanken)
Quellen: db:Europe PMC (3) · db:openalex (8) · db:crossref (1)
- db:Europe PMC et al.. (2026). "Multi-target bioactive M(II) pyridine-diamine complexes: synthesis, characterization, in vitro and in silico evaluation.". https://doi.org/10.1016/j.bioorg.2026.109808 →
- db:Europe PMC et al.. (2026). "Novel pyridine-heterocycle hybrids: synthesis via Hantzsch and Biginelli reactions, docking simulations, and anticancer activity.". https://doi.org/10.1039/d6ra00243a →
- db:Europe PMC et al.. (2026). "CuO@Pyridine Composite for Efficient Removal of Malachite Green and Cd(II) from Water: Adsorption Performance and Mechanistic Insights.". https://doi.org/10.3390/molecules31091501 →
- db:openalex Xiubei Yang, Qizheng An, Xuewen Li et al.. (2024). "Charging modulation of the pyridine nitrogen of covalent organic frameworks for promoting oxygen reduction reaction". Nature Communications. https://doi.org/10.1038/s41467-024-46291-y →
- db:openalex Edward Spence, Leonides Calvo-Bado, Paul D. Mines et al.. (2021). "Metabolic engineering of Rhodococcus jostii RHA1 for production of pyridine-dicarboxylic acids from lignin". Microbial Cell Factories. https://doi.org/10.1186/s12934-020-01504-z →
- db:openalex Chenggang Wang, Xiaoen Huang, Qi Li et al.. (2019). "Extracellular pyridine nucleotides trigger plant systemic immunity through a lectin receptor kinase/BAK1 complex". Nature Communications. https://doi.org/10.1038/s41467-019-12781-7 →
- db:crossref Satyanarayan Pal. (2018). "Pyridine: A Useful Ligand in Transition Metal Complexes". Pyridine. https://doi.org/10.5772/intechopen.76986 →
- db:openalex Yuhei Katsuma, Hiroki Asakawa, Makoto Yamashita. (2017). "Reactivity of highly Lewis acidic diborane(4) towards pyridine and isocyanide: formation of boraalkene–pyridine complex and ortho-functionalized pyridine derivatives". Chemical Science. https://doi.org/10.1039/c7sc04759b →
- db:openalex Ying Chen, Mrudula Pullambhatla, Catherine A. Foss et al.. (2011). "2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer". Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-1357 →
- db:openalex Nadine Pollak, Christian Dölle, Mathias Ziegler. (2007). "The power to reduce: pyridine nucleotides – small molecules with a multitude of functions". Biochemical Journal. https://doi.org/10.1042/bj20061638 →
- db:openalex Manfred Schlosser, Florence Mongin. (2007). "Pyridine elaboration through organometallic intermediates: regiochemical control and completeness". Chemical Society Reviews. https://doi.org/10.1039/b706241a →
- db:openalex (2000). "NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).". PubMed.
Physikochemische Eigenschaften
Kurzübersicht
Detaillierte Eigenschaften
| Eigenschaft | Wert | Einheit | Bedingungen | Quelle |
|---|---|---|---|---|
| Dichte (ρ) | 0.9819 | g/cm³ | 20 °C (68 °F) | Reid, Prausnitz, Poling 4th ed. (1987) |
| Schmelzpunkt (mp) | -41.60 °C (-42.9 °F) | 1 atm | Reid, Prausnitz, Poling 4th ed. (1987) | |
| Siedepunkt (bp) | 115.20 °C (239.4 °F) | 1 atm | Reid, Prausnitz, Poling 4th ed. (1987) | |
| Flammpunkt | 17.00 °C (62.6 °F) | closed cup | Reid, Prausnitz, Poling 4th ed. (1987) | |
| Dampfdruck | 20.800 | mmHg | 25 °C (77 °F) | Reid, Prausnitz, Poling 4th ed. (1987) |
| Wasserlöslichkeit | miscible | g/L | 20 °C (68 °F) | Reid, Prausnitz, Poling 4th ed. (1987) |
| Viskosität (η) | 0.879 | cP | 25 °C (77 °F) | Reid, Prausnitz, Poling 4th ed. (1987) |
| Brechungsindex (nD) | 1.5095 | 20 °C (68 °F), D-line | Reid, Prausnitz, Poling 4th ed. (1987) | |
| pKa | 5.250 | 25 °C (77 °F) | Reid, Prausnitz, Poling 4th ed. (1987) |
🔬 Erweiterte Eigenschaften
| Oberflächenspannung | 36.500 mN/m | 20°C |
| Dielektrizitätskonstante (ε) | 12.400 | 25°C |
| Wärmekapazität (Cp) | 1.704 J/(g·K) | 25°C |
Chemische Kennungen
C1=CC=NC=C1 Datenquellen: PubChem, NIST Chemistry WebBook, CRC Handbook of Chemistry and Physics (103rd ed.)
Zuletzt aktualisiert: 2026-06-24
📡 Spektroskopie — CAS 110-86-1MolGod_SPECHUB_MAIN
Physikalisch-chemische Eigenschaften (DB) 26 Felder MolGod-Score: Primär
| Eigenschaft | Wert | Einheit | Bedingungen | Quelle |
|---|---|---|---|---|
| Schmelzpunkt | -41.60 [4][6][11] | °C | 1 atm | Reid, Prausnitz, Poling 4th ed. (1987) |
| Siedepunkt | 115.20 [4][6][11] | °C | 760 mmHg | Reid, Prausnitz, Poling 4th ed. (1987) |
| Wasserlöslichkeit | miscible [4] | g/L | 20°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Dichte (ρ) | 0.9819 [4] | g/cm³ | 20°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Brechungsindex (n_D) | 1.5095 [4] | — | 20°C, sodium D | Reid, Prausnitz, Poling 4th ed. (1987) |
| Viskosität (η) | 0.879 [4] | cP | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Dampfdruck | 20.800 [4] | mmHg | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Flammpunkt | 17.00 [4] | °C | closed cup | Reid, Prausnitz, Poling 4th ed. (1987) |
| Zündtemperatur | 482.00 [4] | °C | in air | Reid, Prausnitz, Poling 4th ed. (1987) |
| UV λmax | 251 [4][2] | nm | water/MeOH | Reid, Prausnitz, Poling 4th ed. (1987) |
| UV εmax | 2000 [4][2] | M⁻¹·cm⁻¹ | at λmax | Reid, Prausnitz, Poling 4th ed. (1987) |
| UV λmax (alt) | 195 [4][2] | nm | water (n→π*) | Reid, Prausnitz, Poling 4th ed. (1987) |
| pKa₁ | 5.250 [4][2][10] | — | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| logP (Octanol/Wasser) | 0.650 [4][8][9] | — | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| logD (pH 7) | 0.640 [4][8][9] | — | pH 7.4 | Reid, Prausnitz, Poling 4th ed. (1987) |
| Dielektrizitätskonstante (ε) | 12.400 [4] | — | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Oberflächenspannung | 36.500 [4] | mN/m | 20°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Spezifische Wärme (cp) | 1.704 [4] | J/(g·K) | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Wärmeleitfähigkeit (k) | 0.1660 [4] | W/(m·K) | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
| Dipolmoment (μ) | 2.220 [4] | D | gas phase | Reid, Prausnitz, Poling 4th ed. (1987) |
| ΔH Verdampfung | 35.090 [4] | kJ/mol | NBP | Reid, Prausnitz, Poling 4th ed. (1987) |
| ΔH Schmelzen | 8.280 [4] | kJ/mol | at mp | Reid, Prausnitz, Poling 4th ed. (1987) |
| Kritische Temperatur (Tc) | 346.80 [4] | °C | critical point | Reid, Prausnitz, Poling 4th ed. (1987) |
| Kritischer Druck (Pc) | 56.300 [4] | bar | critical point | Reid, Prausnitz, Poling 4th ed. (1987) |
| Azentrischer Faktor (ω) | 0.2426 [4] | — | Pitzer | Reid, Prausnitz, Poling 4th ed. (1987) |
| Ethanol-Löslichkeit | miscible [4] | g/L | 25°C | Reid, Prausnitz, Poling 4th ed. (1987) |
📚 Wissenschaftliche Referenzen (Chicago Author-Date) (12 Quellen)
- Haynes, William M., ed. 2024. CRC Handbook of Chemistry and Physics. 105th ed. Boca Raton: CRC Press/Taylor & Francis. ISBN 978-1-032-55554-4. ↗
- National Institute of Standards and Technology. 2024. "NIST Chemistry WebBook, SRD 69." Gaithersburg, MD: NIST. Accessed 2025-01-01. ↗
- Yaws, Carl L. 2014. The Yaws Handbook of Physical Properties for Hydrocarbons and Chemicals. 2nd ed. Oxford: Gulf Professional Publishing.
- PubChem. 2024. "PubChem Compound Database." National Library of Medicine, National Institutes of Health. Accessed 2025-01-01. ↗
- Marrero, J., and R. Gani. 2001. "Group-Contribution Based Estimation of Pure Component Properties." Fluid Phase Equilibria 183–184: 183–208. ↗
- Joback, K. G., and R. C. Reid. 1987. "Estimation of Pure-Component Properties from Group-Contributions." Chemical Engineering Communications 57 (1–6): 233–243. ↗
- Sangster, J. 1997. Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry. Chichester: Wiley. ISBN 978-0-471-97397-3.
- Mannhold, Raimund, and Han van de Waterbeemd. 2001. "Substructure and Whole Molecule Approaches for Calculating Log P." Journal of Computer-Aided Molecular Design 15 (4): 337–354. ↗
- Perrin, Ditlev D., Boyd Dempsey, and E. P. Serjeant. 1981. pKa Prediction for Organic Acids and Bases. London: Chapman and Hall. ISBN 0-412-21090-5.
- Constantinou, Leonidas, and Rafiqul Gani. 1994. "New Group Contribution Method for Estimating Properties of Pure Compounds." AIChE Journal 40 (10): 1697–1710. ↗
- Ertl, Peter, Bernhard Rohde, and Paul Selzer. 2000. "Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties." Journal of Medicinal Chemistry 43 (20): 3714–3717. ↗
🛡️ Sicherheit — CAS 110-86-1MolGod_SAFEHUB_MAIN
GHS/CLP-Einstufung — Verordnung (EG) Nr. 1272/2008 + UN GHS Rev. 9 (2021).
🚨 Gefahrenhinweise (H)
- H225 — Flüssigkeit und Dampf leicht entzündbar.
- H332 — Gesundheitsschädlich bei Einatmen.
- H312 — Gesundheitsschädlich bei Hautkontakt.
- H302 — Gesundheitsschädlich bei Verschlucken.
🛡 Sicherheitshinweise (P)
- P210 — Von Hitze, heißen Oberflächen, Funken, offenen Flammen und anderen Zündquellenarten fernhalten. Nicht rauchen.
- P273 — Freisetzung in die Umwelt vermeiden.
✓ Harmonisierte Einstufung gemäß Anhang VI der CLP-Verordnung (EG) 1272/2008 (amtliche, verbindliche Einstufung). Indexnummer: 613-002-00-7.
Referenz (Chicago): European Chemicals Agency. "pyridine, Index No. 613-002-00-7." In Table 3 of Annex VI to Regulation (EC) No 1272/2008 (CLP Regulation), 23rd Adaptation to Technical Progress. Helsinki: European Chemicals Agency, 2026. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp.
Übersetzungen: CLP-Verordnung (EG) 1272/2008, Anhang III und IV. Daten: PubChem/NLM.
📚 Konsolidierte wissenschaftliche Referenzen — Chicago Author-Date 10 Quellen
Referenzen aus allen Safety-Hub-Registerkarten gesammelt. CAS: 110-86-1 ·
PubChem ↗
- Parlament Europejski i Rada UE. 2008. "Rozporządzenie (WE) nr 1272/2008 w sprawie klasyfikacji, oznakowania i pakowania substancji (CLP)." Dz.Urz. UE L 353. [↗] GHS, Vorschriften
- United Nations Economic Commission for Europe (UNECE). 2021. "Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Ninth Revised Edition." United Nations, Geneva. [↗] GHS
- Goldfrank, Lewis R., Robert S. Hoffman, Mary Ann Howland, et al.. 2019. "Goldfrank's Toxicologic Emergencies, 11th ed.." McGraw-Hill Education, New York. ISBN 978-1-25-985961-8. Pierwsza pomoc, Toksykologia
- National Institute for Occupational Safety and Health (NIOSH). 2023. "NIOSH Pocket Guide to Chemical Hazards (DHHS Publ. 2005-149)." U.S. Department of Health and Human Services / CDC, Cincinnati, OH. [↗] Pierwsza pomoc, PPE, Toksykologia
- European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms." CEN, Brussels. [↗] PPE
- UNECE. 2023. "European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." United Nations, Geneva. [↗] Utylizacja, Regulacje
- National Fire Protection Association (NFPA). 2022. "NFPA 400 — Hazardous Materials Code." NFPA, Quincy, MA. [↗] Magazynowanie
- Urben, P.G. (ed.). 2017. "Bretherick's Handbook of Reactive Chemical Hazards, 8th ed.." Butterworth-Heinemann / Elsevier, Oxford. [↗] Magazynowanie
- Ministerstwo Klimatu i Środowiska RP. 2023. "Baza danych o produktach i opakowaniach oraz o gospodarce odpadami (BDO)." Ministerstwo Klimatu i Środowiska, Warszawa. [↗] Utylizacja
- International Agency for Research on Cancer (IARC / WHO). 2024. "IARC Monographs on the Identification of Carcinogenic Hazards to Humans — List of Classifications." WHO, Lyon. [↗] Toksykologia
Registerkarten mit eigenen Referenzen (Emergency, PPE, Storage, Waste) enthalten zusätzliche bibliografische Einträge in ihren jeweiligen Abschnitten.
Analytische Statistik (t-Test · RSD · Grubbs · Q-Dixon) ICH Q2
Fügen Sie eine Serie von Messwiederholungen ein (CSV oder eine Zahl pro Zeile). Der Rechner berechnet Mittelwert, Standardabweichung und 95% CI und erkennt Ausreißer (Grubbs + Dixon Q).
📐 Statistische Formeln
x̄ = Σxᵢ / n— arithmetisches Mittels² = Σ(xᵢ - x̄)² / (n-1)— Stichprobenvarianzs = √s²— StandardabweichungRSD% = (s / x̄) × 100%— relative StandardabweichungCI₉₅ = x̄ ± t(0.05, n-1) × s / √n— Student's tG = |xᵢ - x̄| / s— Grubbs-TestQ = |xsuspect - xnearest| / |xmax - xmin|— Dixon Q-test
Quelle: ICH Q2(R2) Validation of Analytical Procedures · ICH PDF ↗
Puffer-Rezept-Rechner EINZIGARTIG
Wählen Sie einen Puffer aus der Liste von 20 gängigen Systemen → geben Sie den Ziel-pH-Wert ein → Sie erhalten ein exaktes Rezept mit den einzuwiegenden Massen.
Schritt 1: Puffersystem wählen
📜 Rezeptverlauf (letzte 10)
🔧 Fehlerbehebung HPLC — Entscheidungsbaum 6 häufige Probleme
Diagnose der 12 häufigsten HPLC-Probleme mit Entscheidungsbaum (5 Schritte pro Problem). Quelle: Snyder/Kirkland/Dolan 3rd ed. Chapter 17 + LCGC LC Troubleshooting columns 1989-2024.
Verbreiterte Peaks (broad peaks) medium
Symptom: Alle Peaks im Chromatogramm sind breiter als erwartet (FWHM > 2× normal)
🔍 Diagnosebaum:
-
1. Prüfen Sie, ob alle Peaks verbreitert sind oder nur einige
→ JA: Alle → instrumentelles Problem (Säule oder System)
→ NEIN: Nur einige → chemisches Problem (Wechselwirkung mit der Säule bei bestimmten Analyten) -
2. Tauschen Sie eine Testsäule ein — verschwindet das Problem?
→ JA: SÄULE verschlissen — Packung beschädigt, Void in den ersten mm. Ersetzen.
→ NEIN: Problem im LC-System -
3. Prüfen Sie das Totvolumen (dead volume) — Injektionsschleife, Verbindungen, Detektor
→ JA: Schleife > 100 µL für eine 4.6-mm-Säule oder lose Verbindungen → Ferrulen ersetzen, Kapillaren kürzen
→ NEIN: Diagnose fortsetzen -
4. Temperaturtest: Erhöhen Sie die Säule von 25°C auf 40°C
→ JA: Schmalere Peaks → Massentransferkinetik zu langsam (T erhöhen)
→ NEIN: Continue -
5. Prüfen Sie die Flussrate gegenüber dem van-Deemter-Optimum für diese Säule
→ JA: Optimum für 4.6mm/5µm = 1.0 mL/min, für 2.1mm/3µm = 0.4 mL/min
→ NEIN: Continue
- Säule verschlissen (>2000 Injektionen ohne Vorsäule)
- Totvolumen des Systems > 100 µL (falsche Schleife, lange Kapillaren, lose Ferrulen)
- Temperatur zu niedrig (Massentransferkinetik)
- Flussrate außerhalb des van-Deemter-Optimums
- Probenlösungsmittel stärker als mobile Phase A
- ✓ Säule ersetzen (bei >2000 Injektionen)
- ✓ Alle Verbindungen prüfen — Kapillaren so kurz wie möglich
- ✓ Säulentemperatur auf 40°C erhöhen (wenn die Substanz stabil ist)
- ✓ Fluss auf das van-Deemter-Optimum reduzieren
- ✓ Probe in mobiler Phase A lösen (nicht in reinem Organischem)
Peak-Tailing (Tailing, T > 1.5) high
Symptom: Peaks haben einen verlängerten "Schwanz" auf der Seite der späten Elution (Asymmetrie T = b/a > 1.5 gemäß USP)
🔍 Diagnosebaum:
-
1. Enthält die Substanz basische Gruppen (Amino, Pyridin)?
→ JA: Ja → Silanol-Wechselwirkungen! Fügen Sie 0.1% TFA oder 5-10 mM TEA zur mobilen Phase A hinzu.
→ NEIN: Continue -
2. Prüfen Sie den pH der mobilen Phase gegenüber dem pKa der Substanz
→ JA: pH = pKa ± 1 → teilweise Ionisierung, Peak-Split. Gehen Sie pH ≥ 2 Einheiten vom pKa weg.
→ NEIN: Continue -
3. Prüfen Sie das Alter der Säule (>1500 Injektionen?)
→ JA: Ja → freigelegte Silanole (Column Bleed). Ersetzen Sie die Säule durch eine mit höherem Endcapping (XTerra, Symmetry).
→ NEIN: Continue -
4. Enthält die Probe Metalle (Fe, Cu aus Glasfläschchen)?
→ JA: Ja → verwenden Sie klare Typ-II-Fläschchen oder PFA. 0.1mM EDTA zur Probe geben.
→ NEIN: Continue
- Silanol-Wechselwirkungen (basischer Analyt + freie Silanole des Kieselgels)
- pH an der Grenze des Analyt-pKa (Peak-Split)
- Alte Säule (Column Bleed, hohe Silanolaktivität)
- Metalle in der Probe (Chelatbildung → Tailing)
- Säulenüberladung (>50 µg auf einer 4.6mm-Säule)
- ✓ 0.1% TFA (UV) oder 0.1% Ameisensäure (LC-MS) zur mobilen Phase A hinzufügen
- ✓ Wählen Sie eine Säule mit hochreinem Endcapping: Waters XBridge BEH, Phenomenex Kinetex
- ✓ Arbeiten Sie bei pH ≥ 2 Einheiten vom pKa entfernt
- ✓ 0.1mM EDTA zur Probe (Fe/Cu-Chelatbildung)
- ✓ Injektionsvolumen auf ≤ 20 µL für eine 4.6mm-Säule reduzieren
Grundliniendrift (Baseline Drift) medium
Symptom: Die Grundlinie steigt oder fällt systematisch über >5 Minuten
🔍 Diagnosebaum:
-
1. Verwenden Sie einen Gradienten (B% steigt)?
→ JA: Ja → unterschiedliche Absorption der Phasen A vs. B bei dλ. Lösungsmittelwechsel im UV-Cutoff. Prüfen Sie die UV-Absorption des %-Organik-Anteils.
→ NEIN: Weiter (isokratisch) -
2. Prüfen Sie die Säulentemperatur — ist sie auf ±0.5°C stabil?
→ JA: Ja (stabil) → weiter
→ NEIN: Instabil → Säulenthermostat einschalten (>25°C kontrolliert) -
3. Test: Autosampler ausschalten, nur Pumpe+Säule+Detektor betreiben
→ JA: Drift verschwindet → Autosampler-Kontamination (Nadel, Septum reinigen)
→ NEIN: Continue -
4. Prüfen Sie das Alter der Lampe (D2 für UV)
→ JA: Ja (>1500 Stunden) → Lampe ersetzen
→ NEIN: Continue
- Gradientenelution mit unterschiedlichem UV-Cutoff der Phasen
- Instabile Säulentemperatur
- Autosampler-Kontamination von Nadel/Septum
- UV-Lampe alt (>1500h)
- Detektor-Durchflusszelle verschmutzt
- Säule nicht äquilibriert (<10 Säulenvolumina)
- ✓ Säule 10-15 Säulenvolumina bei 100% A voräquilibrieren
- ✓ Säulenthermostat ein, T 30-40°C stabil
- ✓ Detektor-Durchflusszelle mit 50:50 ACN:H2O reinigen
- ✓ D2-Lampe ersetzen, wenn >1500h
- ✓ Grundlinien-Subtraktion verwenden (Chromeleon, native Empower-Funktion)
Kein Peak / verlorener Peak (no peak) critical
Symptom: Der erwartete Analyt-Peak erscheint nicht im Chromatogramm
🔍 Diagnosebaum:
-
1. Hat die Injektion tatsächlich stattgefunden?
→ JA: Prüfen Sie das Autosampler-Log, den Pumpendruck (sollte bei der Injektion abfallen)
→ NEIN: Autosampler-Problem → Schleife, Nadel, Probe im Fläschchen prüfen -
2. Ist die Probe im Fläschchen (korrektes Volumen, nicht verdunstet)?
→ JA: Continue
→ NEIN: Keine Probe — erneut pipettieren -
3. Probenstabilität — vor >24h vorbereitet?
→ JA: Ja → Degradation. Bereiten Sie eine frische Probe vor.
→ NEIN: Continue -
4. Prüfen Sie die Detektionswellenlänge gegenüber dem λmax der Substanz
→ JA: Detektion bei λ entspricht NICHT dem λmax → kein Signal. DAD 200-400nm scannen.
→ NEIN: Continue -
5. Test: Injizieren Sie einen reinen Standard (bekannter Konzentration, frisch)
→ JA: Standard ergibt einen Peak → Problem mit der Probe (Matrix, Derivatisierung)
→ NEIN: Kein Peak auch mit dem Standard → Systemproblem (Säule, Phase, Gradient)
- Probe nicht aus dem Fläschchen entnommen (Autosampler-Fehler)
- Probe degradiert (>24h pH/Temp/Licht)
- Detektion bei falscher Wellenlänge
- Falsche mobile Phase (z. B. vergessenes TFA)
- Säule umgekehrt / falsche stationäre Phase
- Substanz eluiert an der Front (V0) → nicht retendiert, nicht sichtbar
- ✓ Frische Probe nach dem exakten Protokoll neu vorbereiten
- ✓ UV-Vis-DAD-Scan 200-400nm + Suche nach λmax
- ✓ Zusammensetzung der mobilen Phase prüfen — TFA hinzugefügt?
- ✓ Umgekehrte Säulenrichtung testen (vorsichtig!)
- ✓ Bei Retention <1 min — % B verringern, MeOH statt ACN
- ✓ Prüfen Sie die Tabelle "expected_rt" in wp_molgod_hplc_methods
Druck zu hoch (pressure too high) critical
Symptom: Pumpendruck > 80% des Säulenmaximums oder System-Shutdown mit High-Pressure-Fehler
🔍 Diagnosebaum:
-
1. Prüfen Sie, ob die Säule korrekt angeschlossen ist (Pfeilrichtung)
→ JA: OK
→ NEIN: Säule umgekehrt → umdrehen (niemals "rückwärts" betreiben) -
2. Test: Säule aus dem System entfernen, nur Pumpe+Detektor betreiben
→ JA: Druck fällt auf <50 bar → Problem in der Säule (verstopft)
→ NEIN: Druck bleibt hoch → In-Line-Filter verstopft, Fritte verschmutzt -
3. Prüfen Sie den Vorsäulenfilter (In-Line-Fritte)
→ JA: Verschmutzt und braun → ersetzen
→ NEIN: Continue -
4. Säule rückwärts mit 50:50 ACN:H2O spülen, ohne die Säule — verschwindet es?
→ JA: Partikel im ersten mm stecken geblieben — 30 min Spülung kann sie wiederherstellen
→ NEIN: Säule ersetzen
- In-Line-Filter (Fritte) mit Partikeln verstopft
- Puffer-Aussalzung (Ausfällung bei hohem %B)
- Probe enthält Schwebstoffe (0.22 µm vor der Injektion filtrieren)
- Säule verstopft (Column Bed Compaction)
- Gradient mit Pufferphase + viel Organik → Salzausfällung
- ✓ Probe IMMER durch 0.22 µm PVDF vor der Injektion filtrieren
- ✓ In-Line-Filter alle 100 Injektionen ersetzen (oder wenn der Druck >20% steigt)
- ✓ Verwenden Sie NICHT >20mM Phosphatpuffer + >70% ACN (das Salz fällt aus)
- ✓ Säule 30 min mit 50:50 ACN:H2O in umgekehrter Richtung spülen (wenn vom Hersteller zugelassen)
- ✓ Vorsäule 4×3mm zum Schutz der Hauptsäule
Geisterpeaks (Ghost Peaks) high
Symptom: Unerklärte Peaks im Chromatogramm, die in der Kalibrierung fehlen
🔍 Diagnosebaum:
-
1. Test: Blindinjektion (reines Probenlösungsmittel)
→ JA: Ein Geisterpeak erscheint → Kontamination des Systems oder der Eluenten
→ NEIN: Erscheint nur mit der Probe → Matrix -
2. Wächst der Geisterpeak mit dem Gradienten (eluiert bei hohem %B)?
→ JA: Ja → überladene Säule oder stark retendiert aus einem vorherigen Lauf
→ NEIN: Unabhängig vom Gradienten → Autosampler-Verschleppung -
3. Increase carryover wash (between injections)
→ JA: Hilft → Verschleppung war die Ursache. Stärkeres Waschprotokoll.
→ NEIN: Continue -
4. Reinwasser-Injektion — gibt es einen Peak?
→ JA: Ja → Kontamination der Wasserquelle (Organik aus dem DI-System)
→ NEIN: Continue
- Verschleppung in Autosampler-Nadel/-Schleife
- Eluent-Kontamination (auch in HPLC-Qualität)
- Stark retendierte Komponenten aus vorherigen Läufen
- Kunststoff in den Fläschchen (Phthalate, PEG aus den Kappen)
- DI-Wasser unzureichend gereinigt
- ✓ Waschprotokoll verstärken: 100% B → 100% A → 50:50 (3 Zyklen)
- ✓ Starke Wäsche: 100% DMSO oder 100% MeOH vor der Kalibrierung
- ✓ Eluenten im Zweifelsfall durch 0.22 µm PTFE filtrieren
- ✓ Braunglas + Teflon-beschichtete Kappen für Proben verwenden
- ✓ Periodische Gradientenrampe auf 100% B für 10 min (Reinigung)
📚 Wissenschaftliche Referenzen (Chicago Author-Date) — zum Aufklappen klicken
- Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. John Wiley & Sons. Chapter 17 (Troubleshooting) pp. 559-616. ISBN 978-0-470-16754-0. https://doi.org/10.1002/9780470508183 [link ↗]
- Dolan, John W.. 2014. LC Troubleshooting (monthly column 1989-2024). LCGC North America. [link ↗] — John Dolan 35-letnia seria miesięcznych artykułów problemowych
- Kromidas, Stavros. 2017. HPLC Made to Measure: A Practical Handbook for Optimization. 2nd ed. Wiley-VCH. ISBN 978-3-527-31377-1. — Praktyczny przewodnik problem-solving dla labs analitycznych
- Dolan, John W.. 2013. When to Modify Method Conditions. 192-199. [link ↗] — Decision flow for changing flow rate / temperature / %B vs swapping columns.
- Dong, Michael W.. 2019. HPLC and UHPLC for Practicing Scientists. 2nd ed. Wiley. ISBN 978-1-119-31378-3. https://doi.org/10.1002/9781119313793 [link ↗] — Chapter 9 covers troubleshooting modern UHPLC systems (sub-2 µm particles).
- Meyer, Veronika R.. 2010. Practical High-Performance Liquid Chromatography. 5th ed. Wiley. ISBN 978-0-470-68218-0. — Solid step-by-step problem isolation chapter (eluents, columns, instruments).
- Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. Practical HPLC Method Development. 2nd ed. Wiley. ISBN 978-0-471-00703-6. — Method-development companion volume with troubleshooting cross-refs.
- Carr, Peter W.. 2009. The new physical chemistry of HPLC. 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗] — Theoretical basis for diagnosing efficiency losses (mass-transfer, eddy diffusion).
- Heyden, Yvan Vander, et al.. 2009. Robustness of pharmaceutical liquid chromatographic methods. 2120-2129. https://doi.org/10.1016/j.jchromb.2008.10.052 [link ↗] — How to diagnose method failures vs. system failures (Plackett-Burman).
- Engelhardt, Heinz. 2014. 100 Years of Chromatography. 2nd ed. Wiley-VCH. ISBN 978-3-527-33473-5. — Historical context for ghost-peak phenomenology (silica chemistry).
- Stoll, Dwight R., and Peter W. Carr. 2017. Two-Dimensional Liquid Chromatography: A State of the Art Tutorial. 519-531. https://doi.org/10.1021/acs.analchem.6b03506 [link ↗]
- Carr, Peter W.. 2009. The new physical chemistry of HPLC. 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗]
- Wu, Naijun, and Anton M. Clausen. 2007. Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations. 1167-1182. https://doi.org/10.1002/jssc.200700026 [link ↗]
- Engelhardt, Heinz. 2014. 100 Years of Chromatography. 2nd ed. Wiley-VCH. ISBN 978-3-527-33473-5.
- Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. Probabilistic approach to peak deconvolution in chromatography. 8525-8531. https://doi.org/10.1021/ac101742z [link ↗]
ADMET — Pharmakologisches Profil
Drug-Likeness-Radardiagramm (Lipinski Ro5 / Veber). Grüne Zone = Übereinstimmung mit den Kriterien.
Vorhersagedaten — in silico berechnete Eigenschaften (SMILES/RDKit). Sie ersetzen keine klinischen Studien. Nicht zur Arzneimittelbewertung ohne experimentelle Verifizierung verwenden.
| Eigenschaft | Wert | Bewertung |
|---|---|---|
| Resorption (GI) | hoch | ✓ |
| BHS-Permeabilität | ja (durchdringt) | |
| Bioverfügbarkeit (Daina 2017) | 55% | |
| CYP450-Profil | CYP1A2 non-inhibitorCYP2C9 non-inhibitorCYP2C19 non-inhibitorCYP2D6 non-inhibitorCYP3A4 non-inhibitor | |
| PAINS-Warnungen | 1 | ⚠ |
| Brenk-Warnungen | 0 | ✓ |
| pKa (pH 7.4) | 5.25 (curated) | |
| hERG (Kardiotox.) | ✓ nein | |
| P-gp-Substrat | — | |
| Ames-Mutagenität | ✓ nein | |
| DILI (Hepatotox.) | — | |
| LogS (Wasserlösl.) | — | |
Quellen (ADMET-Methodik)
- Lipinski, Christopher A., Franco Lombardo, Beryl W. Dominy, and Paul J. Feeney. 1997. "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings." Advanced Drug Delivery Reviews 23 (1-3): 3-25.
- Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, et al. 2002. "Molecular properties that influence the oral bioavailability of drug candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
- Daina, Antoine, Olivier Michielin, and Vincent Zoete. 2017. "SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness." Scientific Reports 7: 42717.
- Egan, William J., and Gregory Lauri. 2002. "Prediction of intestinal permeability." Advanced Drug Delivery Reviews 54 (3): 273-289.
- Baell, Jonathan B., and Georgina A. Holloway. 2010. "New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries." Journal of Medicinal Chemistry 53 (7): 2719-2740.
- Brenk, Ruth, Alessandro Schipani, Daniel James, et al. 2008. "Lessons learnt from assembling screening libraries for drug discovery for neglected diseases." ChemMedChem 3 (3): 435-444.
- Ertl, Peter, and Ansgar Schuffenhauer. 2009. "Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions." Journal of Cheminformatics 1: 8.
- Bickerton, G. Richard, Gaia V. Paolini, Jérémy Besnard, Sorel Muresan, and Andrew L. Hopkins. 2012. "Quantifying the Chemical Beauty of Drugs." Nature Chemistry 4 (2): 90-98.
- Hopkins, Andrew L., and Colin R. Groom. 2002. "The Druggable Genome." Nature Reviews Drug Discovery 1 (9): 727-730.
- Ghose, Arup K., Vellarkad N. Viswanadhan, and John J. Wendoloski. 1999. "A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery." Journal of Combinatorial Chemistry 1 (1): 55-68.
- Tice, Raymond R., Christopher P. Austin, Robert J. Kavlock, and John R. Bucher. 2013. "Improving the Human Hazard Characterization of Chemicals: A Tox21 Update." Environmental Health Perspectives 121 (7): 756-765.
- Leeson, Paul D., and Brian Springthorpe. 2007. "The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry." Nature Reviews Drug Discovery 6 (11): 881-890.
- Hann, Michael M. 2011. "Molecular Obesity, Potency and Other Addictions in Drug Discovery." MedChemComm 2 (5): 349-355.
- Davies, Mark, Michał Nowotka, George Papadatos, et al. 2015. "ChEMBL Web Services: Streamlining Access to Drug Discovery Data and Utilities." Nucleic Acids Research 43 (W1): W612-W620.
- Walters, W. Patrick, and Mark A. Murcko. 2002. "Prediction of 'Drug-Likeness.'". Advanced Drug Delivery Reviews 54 (3): 255–271. https://doi.org/10.1016/S0169-409X(02)00003-0.
- Congreve, Miles, Robin Carr, Christopher Murray, and Harren Jhoti. 2003. "A 'Rule of Three' for Fragment-Based Lead Discovery?" Drug Discovery Today 8 (19): 876–877. https://doi.org/10.1016/S1359-6446(03)02831-9.
- Brenk, Ruth, Alessandro Schipani, Daniel James, Agata Krasowski, Iain Hugh Gilbert, Julie Frearson, and Paul Graham Wyatt. 2008. "Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases." ChemMedChem 3 (3): 435-444.
- Schomburg, Karen T., Sascha Bietz, Hans Briem, Andrea M. Henzler, Stefan Urbaczek, and Matthias Rarey. 2014. "Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening." Journal of Chemical Information and Modeling 54 (6): 1676-1686.
- Bemis, Guy W., and Mark A. Murcko. 1996. "The Properties of Known Drugs. 1. Molecular Frameworks." Journal of Medicinal Chemistry 39 (15): 2887-2893.
- Schomburg, Karen T., and Matthias Rarey. 2014. "What Is the Potential of Structure-Based Target Prediction Methods?" Future Medicinal Chemistry 6 (17): 1987-1989.
- da Silva, Carlos Marques, Daniel Leite da Silva, Luzia Valentina Modolo, Rosemeire B. Alves, Maria A. de Resende, Cleide V. B. Martins, and Ângelo de Fátima. 2011. "Schiff Bases: A Short Review of Their Antimicrobial Activities." Journal of Advanced Research 2 (1): 1-8. ↗
- et al.. (2026). "Multi-target bioactive M(II) pyridine-diamine complexes: synthesis, characterization, in vitro and in silico evaluation.". https://doi.org/10.1016/j.bioorg.2026.109808
- et al.. (2026). "Novel pyridine-heterocycle hybrids: synthesis via Hantzsch and Biginelli reactions, docking simulations, and anticancer activity.". https://doi.org/10.1039/d6ra00243a
- et al.. (2026). "CuO@Pyridine Composite for Efficient Removal of Malachite Green and Cd(II) from Water: Adsorption Performance and Mechanistic Insights.". https://doi.org/10.3390/molecules31091501
- Xiubei Yang, Qizheng An, Xuewen Li et al.. (2024). "Charging modulation of the pyridine nitrogen of covalent organic frameworks for promoting oxygen reduction reaction". Nature Communications. https://doi.org/10.1038/s41467-024-46291-y
- Edward Spence, Leonides Calvo-Bado, Paul D. Mines et al.. (2021). "Metabolic engineering of Rhodococcus jostii RHA1 for production of pyridine-dicarboxylic acids from lignin". Microbial Cell Factories. https://doi.org/10.1186/s12934-020-01504-z
- Chenggang Wang, Xiaoen Huang, Qi Li et al.. (2019). "Extracellular pyridine nucleotides trigger plant systemic immunity through a lectin receptor kinase/BAK1 complex". Nature Communications. https://doi.org/10.1038/s41467-019-12781-7
- Satyanarayan Pal. (2018). "Pyridine: A Useful Ligand in Transition Metal Complexes". Pyridine. https://doi.org/10.5772/intechopen.76986
- Yuhei Katsuma, Hiroki Asakawa, Makoto Yamashita. (2017). "Reactivity of highly Lewis acidic diborane(4) towards pyridine and isocyanide: formation of boraalkene–pyridine complex and ortho-functionalized pyridine derivatives". Chemical Science. https://doi.org/10.1039/c7sc04759b
- Ying Chen, Mrudula Pullambhatla, Catherine A. Foss et al.. (2011). "2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer". Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-1357
- Nadine Pollak, Christian Dölle, Mathias Ziegler. (2007). "The power to reduce: pyridine nucleotides – small molecules with a multitude of functions". Biochemical Journal. https://doi.org/10.1042/bj20061638
- Manfred Schlosser, Florence Mongin. (2007). "Pyridine elaboration through organometallic intermediates: regiochemical control and completeness". Chemical Society Reviews. https://doi.org/10.1039/b706241a
- (2000). "NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).". PubMed.
- Anonymous. 2025. "Review for "Magnesium Borohydride Pyridine Derivatives as Solid Electrolytes for All-Solid-State Batteries.". https://doi.org/10.1039/d5ta00239g/v1/review1. [DOI ↗]
- Anonymous. 2025. "Review for "Magnesium Borohydride Pyridine Derivatives as Solid Electrolytes for All-Solid-State Batteries.". https://doi.org/10.1039/d5ta00239g/v2/review1. [DOI ↗]
- Anonymous. 2025. "Review for "Magnesium Borohydride Pyridine Derivatives as Solid Electrolytes for All-Solid-State Batteries.". https://doi.org/10.1039/d5ta00239g/v1/review2. [DOI ↗]
- Jakob B. Grinderslev, Torben Rene Jensen. 2025. "Author response for "Magnesium Borohydride Pyridine Derivatives as Solid Electrolytes for All-Solid-State Batteries.". https://doi.org/10.1039/d5ta00239g/v2/response1. [DOI ↗]
- Anonymous. "A Thieno[2,3b]pyridine-Flanked Diketopyrrolopyrrole Polymer as an nType Polymer Semiconductor for All-Polymer Solar Cells and Organic Field-Effect Transistors.". https://doi.org/10.1021/acs.macromol.7b00934.s001. [DOI ↗]
- Bolton, Evan E., Yanli Wang, Paul A. Thiessen, and Stephen H. Bryant. 2008. "PubChem: Integrated Platform of Small Molecules and Biological Activities." Annual Reports in Computational Chemistry 4: 217-241. [DOI ↗]
- Kim, Sunghwan, Jie Chen, Tiejun Cheng, et al. 2023. "PubChem 2023 update." Nucleic Acids Research 51 (D1): D1373-D1380. [DOI ↗]
- Kim, Sunghwan, Tiejun Cheng, Jianyong He, Chen Cheng, et al. 2021. "PubChem Protein, Pathway, Reaction, and Disease Specifications." Journal of Cheminformatics 13: 16. [DOI ↗]
- Hähnke, Volker D., Sunghwan Kim, and Evan E. Bolton. 2018. "PubChem chemical structure standardization." Journal of Cheminformatics 10: 36. [DOI ↗]
- Wang, Yanli, Stephen H. Bryant, Tiejun Cheng, Jiyao Wang, et al. 2017. "PubChem BioAssay: 2017 update." Nucleic Acids Research 45 (D1): D955-D963. [DOI ↗]
- Cheng, Tiejun, et al. 2014. "Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge." Journal of Chemical Information and Modeling 54 (3): 793-805. [DOI ↗]
- Wilkinson, Mark D., et al. 2016. "The FAIR Guiding Principles for scientific data management and stewardship." Scientific Data 3: 160018. [DOI ↗]
- Piotr Tomasik. 1985. "Pyridine-metal complexes." Wiley. ↗
- Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, Brian R. Smith, Keith W. Ward, and Kenneth D. Kopple. 2002. "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
- Levitt, David. 2024. "Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids." ADMET and DMPK. https://doi.org/10.5599/admet.2414. [DOI ↗]
- Notario, Dion, Munzir, Angela Marietha, Novella, Yulina, Hananta, Linawati. 2024. "Impact of lactoferrin supplementation on cotrimoxazole pharmacokinetics: A preliminary clinical investigation." ADMET and DMPK. https://doi.org/10.5599/admet.2358. [DOI ↗]
- ECHA. 2024. "REACH Guidance." European Chemicals Agency. ↗
- Sridharan, Kannan, Al Banna, Rashed, Husain, Aysha. 2021. "Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model." ADMET and DMPK. https://doi.org/10.5599/admet.909. [DOI ↗]
- Cabana, Bernard E.. 1984. "Bioavailability and Pharmacokinetics in Drug Development." Pharmacokinetics: 113-132. https://doi.org/10.1007/978-1-4613-2799-8_12. [DOI ↗]
- Groom, Colin R., Ian J. Bruno, Matthew P. Lightfoot, and Suzanna C. Ward. 2016. "The Cambridge Structural Database." Acta Crystallographica Section B 72 (2): 171-179. ↗
🧪 Assistent zur Lösungsherstellung (Smart Prep) MolGod_PREP_2
Geben Sie ein, was Sie zubereiten möchten — ich erstelle eine SOP
📚 Überblick über die wissenschaftliche Literatur — CAS 110-86-1MolGod_LITHUB_MAIN
⭐ Wichtigste Erkenntnisse (wissenschaftliche Literatur) 9 Publikationen
110-86-1
— multi-criteria ranking (W12): 30% Zitierungen · 20% Aktualität · 20% Thema · 15% historisch · 15% Open Access.
-
#1Villa-Reyna AL, Perez-Velazquez M, González-Félix ML et al. (2024) · International journal of molecular sciencesWarum es wichtig ist: Aktuell (2024) · Übersichtsarbeit · open access
-
#2Choi W, Jang A, Hong S (2025) · Journal of the American Chemical SocietyWarum es wichtig ist: Aktuell (2025) · open access
-
#3Laurent R, Maraval V, Bernardes-Génisson V et al. (2024) · Molecules (Basel, Switzerland)Warum es wichtig ist: Aktuell (2024) · Übersichtsarbeit · open access
-
#4Redway A, Spry C, Brown A et al. (2024) · International journal for parasitology. Drugs and drug resistanceWarum es wichtig ist: Aktuell (2024) · open access
-
#5Douka MD, Sigala IM, Gabriel C et al. (2025) · Molecules (Basel, Switzerland)Warum es wichtig ist: Aktuell (2025) · open access
-
#6Aruchamy B, Drago C, Russo V et al. (2023) · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical SciencesWarum es wichtig ist: Aktuell (2023) · open access
-
#7Grau J, Caubet A, Roubeau O et al. (2020) · Chembiochem : a European journal of chemical biologyWarum es wichtig ist: Open access
-
#8Koneru PC, Francis AC, Deng N et al. (2019) · eLifeWarum es wichtig ist: Open access
-
#9Şener N, Aldwib AEO (2024) · Chemistry & biodiversityWarum es wichtig ist: Aktuell (2024)
📚 REFERENZEN (Gesammelte Bibliografie, Chicago Author-Date) 108 Einträge
Alle wissenschaftlichen Quellen, die in den Akkordeons oben für CAS 110-86-1 zitiert werden.Format: Chicago Manual of Style, 17. Aufl., Autor-Datum-System.
🗄️ Wissenschaftliche Datenbanken
- NIST. 2026. NIST Chemistry WebBook: CAS 110-86-1. Gaithersburg, MD: National Institute of Standards and Technology. https://webbook.nist.gov/cgi/cbook.cgi?ID=110-86-1. (Accessed 2026-11-12.)
- AIST. 2026. Spectral Database for Organic Compounds (SDBS): CAS 110-86-1. Tsukuba, Japan: National Institute of Advanced Industrial Science and Technology. https://sdbs.db.aist.go.jp/. (Accessed 2026-11-12.)
- PubChem. 2026. PubChem Compound Summary: CAS 110-86-1. Bethesda, MD: National Center for Biotechnology Information (NCBI), National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/#query=110-86-1. (Accessed 2026-11-12.)
- ECHA. 2026. C&L Inventory and REACH Registration: CAS 110-86-1. Helsinki: European Chemicals Agency. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp. (Accessed 2026-11-12.)
📐 Standards / Richtlinien
- ICH. 2026. "ICH Harmonised Guideline: CAS 110-86-1." Geneva: International Council for Harmonisation. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf. (Accessed 2026-11-12.)
- National Fire Protection Association (NFPA). 2024. "NFPA 30: Flammable and Combustible Liquids Code." NFPA, Quincy, MA. https://www.nfpa.org/codes-and-standards/all-codes-and-standards/list-of-codes-and-standards/detail?code=30.
- Occupational Safety and Health Administration (OSHA). 2023. "29 CFR 1910.106 — Flammable Liquids." U.S. Department of Labor, Federal Register. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.106.
- European Chemicals Agency (ECHA). 2024. "Annex VI to Regulation (EC) No 1272/2008 (CLP) — Harmonised Classification and Labelling." ECHA, Helsinki / Official Journal of the European Union. https://echa.europa.eu/regulations/clp/clp-classification.
- European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms — Part 1: Terminology and performance requirements for chemical risks." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=205:110:::::FSP_PROJECT,FSP_ORG_ID:38536,6080&cs=1B0DAA8B85DF42E4A2C70E5D71F0BFA32.
- European Committee for Standardization (CEN). 2001. "EN 166:2001 — Personal eye-protection — Specifications." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:6541&cs=1F1A4E0A78C4DB6A28DBE2E8C29D89DCF.
- European Committee for Standardization (CEN). 2009. "EN 14605:2005+A1:2009 — Protective clothing against liquid chemicals — Performance requirements for clothing with liquid-tight (Type 3) or spray-tight (Type 4) connections." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:21581&cs=1A04A2D3C7CC58E9E6CB58D55F7EBFB7E.
- National Institute for Occupational Safety and Health (NIOSH). 2017. "Recommendations for Chemical Protective Clothing: A Companion to the NIOSH Pocket Guide." U.S. Department of Health & Human Services / CDC. https://www.cdc.gov/niosh/ncpc/default.html.
- Occupational Safety and Health Administration (OSHA). 2011. "Personal Protective Equipment — General requirements." U.S. Department of Labor — 29 CFR 1910.132. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.132.
📖 Bücher
- Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook, 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/Hansen-Solubility-Parameters-A-Users-Handbook/Hansen/p/book/9780849372483.
- Barton, Allan F. M. 1991. CRC Handbook of Solubility Parameters and Other Cohesion Parameters: 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/CRC-Handbook-of-Solubility-Parameters-and-Other-Cohesion-Parameters/Barton/p/book/9780849301766.
- Connors, Kenneth A., Gordon L. Amidon, and Valentino J. Stella. 1986. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, 2nd ed.. New York: Wiley. https://doi.org/10.1002/0471734683.
- Rumble, John R., ed. 2019. CRC Handbook of Chemistry and Physics: 100th Edition. Boca Raton, FL: CRC Press. https://hbcp.chemnetbase.com/.
- Urben, Peter G. 2017. Bretherick's Handbook of Reactive Chemical Hazards, 8th Edition. Academic Press / Elsevier, Oxford. https://www.sciencedirect.com/book/9780081010594.
📘 Monografien
- IARC. 2026. IARC Monographs on the Identification of Carcinogenic Hazards to Humans: CAS 110-86-1. Lyon, France: International Agency for Research on Cancer, World Health Organization. https://monographs.iarc.who.int/list-of-classifications/. (Accessed 2026-11-12.)
📄 Wissenschaftliche Artikel (peer-reviewed)
- Stefanis, Emmanuel, and Costas Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." International Journal of Thermophysics 29: 568-585. https://doi.org/10.1007/s10765-008-0415-z.
- Stoll, Vincent S., and John S. Blanchard. 1990. "Buffers: Principles and Practice: In Methods in Enzymology, vol. 182." San Diego: Academic Press. https://doi.org/10.1016/0076-6879(90)82008-P.
🌐 Websites
- ECHA. 2023. "Guidance on the Application of the CLP Criteria." European Chemicals Agency. https://echa.europa.eu/guidance-documents/guidance-on-clp.
- European Parliament. 2006. "Regulation (EC) No 1907/2006 (REACH)." Official Journal of the European Union L 396: 1–849.
- ECHA. 2023. "Candidate List of Substances of Very High Concern for Authorisation." European Chemicals Agency. https://echa.europa.eu/candidate-list-table.
- European Parliament. 2008. "Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures (CLP)." Official Journal of the European Union L 353: 1–1355.
- ECHA. 2017. "Guidance on the Compilation of Safety Data Sheets." Version 3.1. European Chemicals Agency. ECHA-17-G-01-EN. https://echa.europa.eu/documents/10162/23047722/sds_en.pdf.
- ECHA. 2022. "Restrictions Under REACH — Annex XVII." European Chemicals Agency. https://echa.europa.eu/substances-restricted-under-reach.
- United Nations. 2021. Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 9th revised ed. ST/SG/AC.10/30/Rev.9. New York and Geneva: United Nations. https://unece.org/ghs-rev9-2021.
- ECHA. 2020. "Understanding REACH." European Chemicals Agency. https://echa.europa.eu/regulations/reach/understanding-reach.
- Reid, Prausnitz, Poling 4th ed. (1987). 2026. "Reid, Prausnitz, Poling 4th ed. (1987): CAS 110-86-1." (Accessed 2026-11-12.)
- U.S. OSHA. 2026. "Occupational Safety and Health Guidance: CAS 110-86-1." Washington, DC: U.S. Occupational Safety and Health Administration. https://www.osha.gov/hazwoper. (Accessed 2026-11-12.)
- National Fire Protection Association (2018) — NFPA 472: Standard for Competence of Responders to Hazardous Materials/Weapons of Mass Destruction Incidents https://www.nfpa.org/codes-and-standards/nfpa-472.
- European Union. 2026. "EUR-Lex Legal Database: CAS 110-86-1." Luxembourg: Publications Office of the European Union. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32012L0018. (Accessed 2026-11-12.)
- U.S. National Institute for Occupational Safety and Health (2024) — NIOSH Pocket Guide to Chemical Hazards https://www.cdc.gov/niosh/npg/.
- Snyder, Lloyd R., John W. Dolan, and Joseph J. Kirkland. 2010. Introduction to Modern Liquid Chromatography. Wiley.
- Schoenmakers, Peter J.. 1986. Optimization of Chromatographic Selectivity: A Guide to Method Development. Elsevier.
- Snyder, L. R., and J. W. Dolan. 2007. High-Performance Gradient Elution: The Practical Application of the Linear-Solvent-Strength Model. Wiley.
- Nikitas, Pavlos, and Adrian Pappa-Louisi. 2009. "Retention models for isocratic and gradient elution in reversed-phase liquid chromatography." Journal of Chromatography A 1216: 1737-1755. https://doi.org/10.1016/j.chroma.2008.10.005.
- Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094.
- Dong, Michael W.. 2019. HPLC and UHPLC for Practicing Scientists. Wiley. https://doi.org/10.1002/9781119313793.
- Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." Journal of Separation Science 30: 1167-1182. https://doi.org/10.1002/jssc.200700026.
- Dolan, John W.. 2013. "When to Modify Method Conditions." LCGC North America 31: 192-199. https://www.chromatographyonline.com/view/when-modify-method-conditions.
- Meyer, Veronika R.. 2010. Practical High-Performance Liquid Chromatography. Wiley.
- Engelhardt, Heinz. 2014. 100 Years of Chromatography. Wiley-VCH.
- Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." Analytical Chemistry 82: 8525-8531. https://doi.org/10.1021/ac101742z.
- Van Deemter, J. J., F. J. Zuiderweg, and A. Klinkenberg. 1956. "Longitudinal diffusion and resistance to mass transfer as causes of nonideality in chromatography." https://doi.org/10.1016/0009-2509(56)80003-1.
- Giddings, J. Calvin. 1965. "Dynamics of Chromatography, Part I: Principles and Theory." Marcel Dekker.
- Poppe, Hans. 1997. "Some reflections on speed and efficiency of modern chromatographic methods." https://doi.org/10.1016/S0021-9673(97)00376-2.
- Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." https://doi.org/10.1002/jssc.200700026.
- Carr, Peter W.. 2009. "The new physical chemistry of HPLC." https://doi.org/10.1016/j.chroma.2008.11.094.
- Knox, John H.. 1977. "Practical aspects of LC theory." https://doi.org/10.1093/chromsci/15.9.352.
- Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. "Practical HPLC Method Development." Wiley.
- Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." https://doi.org/10.1021/ac101742z.
- Sadek, Paul C.. 2002. "The HPLC Solvent Guide." Wiley-Interscience.
- Snyder, L. R.. 1978. "Classification of the solvent properties of common liquids." https://doi.org/10.1093/chromsci/16.6.223.
- Reichardt, Christian, and Thomas Welton. 2010. "Solvents and Solvent Effects in Organic Chemistry." Wiley-VCH.
- Vailaya, Anant, and Csaba Horváth. 1998. "Retention thermodynamics in hydrophobic interaction chromatography." https://doi.org/10.1021/ie980212h.
- Krstulović, Andrea M., and Phyllis R. Brown. 1981. "Reversed-phase High-Performance Liquid Chromatography." Wiley.
- Boysen, Reinhard I., and Milton T. W. Hearn. 2009. "Multi-modal HPLC of proteins." https://doi.org/10.1093/chromsci/47.8.645.
- USP General Chapter <621>. 2024. "Chromatography." United States Pharmacopeial Convention. https://www.usp.org/harmonization-standards/pdg/general-chapters/chromatography.
- Foley, Joe P., and John G. Dorsey. 1983. "Equations for calculation of chromatographic figures of merit for ideal and skewed peaks." https://doi.org/10.1021/ac00255a033.
- Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." Wiley. https://doi.org/10.1002/9780470508183.
- Dolan, John W.. 2003. "Peak tailing and resolution." https://www.chromatographyonline.com/view/peak-tailing-and-resolution.
- Kromidas, Stavros. 2017. "HPLC Made to Measure: A Practical Handbook for Optimization." Wiley-VCH.
- Heyden, Yvan Vander, et al.. 2009. "Robustness of pharmaceutical liquid chromatographic methods." https://doi.org/10.1016/j.jchromb.2008.10.052.
- United States Pharmacopeial Convention. 2024. "USP <621> Chromatography." In United States Pharmacopeia and National Formulary, USP 47-NF 42. Rockville, MD: USP. https://www.uspnf.com/.
- European Pharmacopoeia Commission. 2024. "2.2.46 Chromatographic Separation Techniques." In European Pharmacopoeia, 11th ed. Strasbourg: Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
- International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories." Geneva: ISO. https://www.iso.org/standard/66912.html.
- Kolthoff, Izaak Maurits, and Philip J. Elving, eds. 1978. Treatise on Analytical Chemistry, Part I: Theory and Practice. 2nd ed. New York: Wiley-Interscience.
- Skoog, Douglas A., F. James Holler, and Stanley R. Crouch. 2018. Principles of Instrumental Analysis. 7th ed. Boston: Cengage Learning.
- Christian, Gary D., Purnendu K. Dasgupta, and Kevin A. Schug. 2014. Analytical Chemistry. 7th ed. Hoboken, NJ: Wiley.
- EURACHEM/CITAC. 2012. "Quantifying Uncertainty in Analytical Measurement." 3rd ed. EURACHEM/CITAC Guide CG 4. https://www.eurachem.org/images/stories/Guides/pdf/QUAM2012_P1.pdf.
- Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." John Wiley & Sons. https://doi.org/10.1002/9780470508183.
- Dolan, John W.. 2003. "How much resolution is enough?." https://www.chromatographyonline.com/view/how-much-resolution-enough.
- USP General Chapter <621>. 2024. "Chromatography (System Suitability section)." United States Pharmacopeial Convention. https://www.usp.org/harmonization-standards/pdg/general-chapters/chromatography.
- U.S. FDA. 2026. "FDA Guidance and Resources: CAS 110-86-1." Silver Spring, MD: U.S. Food and Drug Administration. https://www.fda.gov/media/74954/download. (Accessed 2026-11-12.)
- Rozet, Eric, et al.. 2013. "Analysis of recent pharmaceutical regulatory documents on analytical method validation." https://doi.org/10.1016/j.chroma.2007.03.111.
- European Medicines Agency (EMA). 2011. "Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009." EMA. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf.
- Kazakevich, Yuri V., and Rosario LoBrutto, eds.. 2007. "HPLC for Pharmaceutical Scientists." Wiley-Interscience. https://doi.org/10.1002/9780470087954.
- AOAC International. 2016. "Appendix F: Guidelines for Standard Method Performance Requirements." AOAC INTERNATIONAL. https://www.aoac.org/wp-content/uploads/2019/08/app_f.pdf.
- International Organization for Standardization. 1994. "ISO 5725-2:1994 Accuracy (Trueness and Precision) of Measurement Methods and Results — Part 2: Basic Method for the Determination of Repeatability and Reproducibility of a Standard Measurement Method." Geneva: ISO. https://www.iso.org/standard/11834.html.
- Grubbs, Frank E. 1950. "Sample Criteria for Testing Outlying Observations." Annals of Mathematical Statistics 21 (1): 27–58.
- Dixon, Wilfrid J. 1950. "Analysis of Extreme Values." Annals of Mathematical Statistics 21 (4): 488–506.
- Snedecor, George W., and William G. Cochran. 1989. Statistical Methods. 8th ed. Ames, IA: Iowa State University Press.
- Student [William Sealy Gosset]. 1908. "The Probable Error of a Mean." Biometrika 6 (1): 1–25.
- International Organization for Standardization. 2005. "ISO 3534-1:2006 Statistics — Vocabulary and Symbols — Part 1: General Statistical Terms and Terms Used in Probability." Geneva: ISO. https://www.iso.org/standard/40145.html.
- Thompson, Michael, Stephen L. R. Ellison, and Roger Wood. 2002. "Harmonized Guidelines for Single-Laboratory Validation of Methods of Analysis." Pure and Applied Chemistry 74 (5): 835–855.
- United Nations Economic Commission for Europe. 2024. European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR), Applicable as from 1 January 2025 (ECE/TRANS/352). Geneva: UNECE. https://unece.org/transport/dangerous-goods/adr-2025-edition.
- International Air Transport Association. 2026. Dangerous Goods Regulations (DGR). 67th ed. Montreal: IATA. https://www.iata.org/en/programs/cargo/dgr/.
- International Maritime Organization. 2024. International Maritime Dangerous Goods (IMDG) Code, 2024 Edition (Amendment 42-24). London: IMO. https://www.imo.org/en/OurWork/Safety/Pages/DangerousGoods-default.aspx.
- United Nations. 2025. Recommendations on the Transport of Dangerous Goods: Model Regulations (Orange Book). 24th revised ed. ST/SG/AC.10/1/Rev.24. New York and Geneva: United Nations. https://unece.org/transport/dangerous-goods/un-model-regulations.
- International Civil Aviation Organization. 2025. Technical Instructions for the Safe Transport of Dangerous Goods by Air (Doc 9284). 2025–2026 ed. Montreal: ICAO. https://www.icao.int/safety/DangerousGoods/Pages/technical-instructions.aspx.
- United States Pharmacopeia (USP) Convention. 2024. "USP General Chapter <621> Chromatography." USP. https://www.usp.org/sites/default/files/usp/document/harmonization/gen-chapter/g05_pf_30_4_2004.pdf.
- European Medicines Agency (EMA). 2011. "Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009." EMA Committee for Medicinal Products for Human Use. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf.
- Sejm RP. 2026. "Internetowy System Aktow Prawnych (ISAP): CAS 110-86-1." Warszawa: Kancelaria Sejmu Rzeczypospolitej Polskiej. https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20200000010. (Accessed 2026-11-12.)
- Ministerstwo Klimatu i Srodowiska. 2026. "Baza Danych o Odpadach (BDO): CAS 110-86-1." Warszawa: Ministerstwo Klimatu i Srodowiska. https://bdo.mos.gov.pl/. (Accessed 2026-11-12.)
- Pohanish, Richard P.. 2017. "Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens." Elsevier.
- Lewis, Richard J.. 2012. "Sax's Dangerous Properties of Industrial Materials." Wiley.
- NIOSH. 2024. "Pocket Guide to Chemical Hazards." U.S. Department of Health and Human Services. https://www.cdc.gov/niosh/npg/.
- United Nations Economic Commission for Europe (UNECE). 2023. "European Agreement concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." UNECE. https://unece.org/transport/standards/transport/dangerous-goods/adr-2025.
- IPCS INCHEM. 2024. "International Programme on Chemical Safety — Waste Management Guidelines." WHO/UNEP/ILO. https://www.inchem.org/.
- International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories." ISO. https://www.iso.org/standard/66912.html.
- World Health Organization. 2010. "WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (WHO Technical Report Series No. 957, Annex 3)." WHO Press. https://www.who.int/publications/m/item/trs957-annex3.
- European Medicines Agency. 2014. "Guideline on Process Validation for Finished Products — Information and Data to Be Provided EMA/CHMP/CVMP/QWP/BWP/70278/2012." European Medicines Agency. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-process-validation-finished-products-information-data-be-provided-regulatory-submissions-revision-1_en.pdf.
- United States Pharmacopeial Convention. 2024. "United States Pharmacopeia and National Formulary, USP 47-NF 42." USP. https://www.uspnf.com/.
- European Pharmacopoeia Commission. 2024. "European Pharmacopoeia 11th Edition." Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
- Pharmaceutical Inspection Co-operation Scheme (PIC/S). 2021. "Guide to Good Manufacturing Practice for Medicinal Products PE 009-15." PIC/S Secretariat, Geneva. https://picscheme.org/en/publications.
- International Pharmaceutical Excipients Council (IPEC) and Pharmaceutical Quality Group (PQG). 2017. "Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients." IPEC-Americas. https://ipecamericas.org/sites/default/files/IPECPQGGMPGuide2017.pdf.




